Manyi Yang

1.3k total citations
41 papers, 998 citations indexed

About

Manyi Yang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Manyi Yang has authored 41 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Manyi Yang's work include Nicotinic Acetylcholine Receptors Study (8 papers), Ion channel regulation and function (7 papers) and MicroRNA in disease regulation (6 papers). Manyi Yang is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (8 papers), Ion channel regulation and function (7 papers) and MicroRNA in disease regulation (6 papers). Manyi Yang collaborates with scholars based in China, United States and Austria. Manyi Yang's co-authors include Anlong Xu, Shengfeng Huang, Shaochun Yuan, Kui Wu, Yanhong Yu, Huiling Liu, Tao Wu, Meiling Dong, Huiqing Huang and Maojun Zhou and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Manyi Yang

40 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manyi Yang China 17 453 396 219 104 77 41 998
Jinyao Mo United States 18 428 0.9× 1.0k 2.6× 138 0.6× 161 1.5× 62 0.8× 24 1.4k
Zhigang Wang China 19 537 1.2× 334 0.8× 150 0.7× 151 1.5× 54 0.7× 51 920
Huaping Tang China 19 570 1.3× 394 1.0× 80 0.4× 102 1.0× 100 1.3× 44 1.2k
Yu Zheng China 21 443 1.0× 801 2.0× 180 0.8× 284 2.7× 91 1.2× 49 1.7k
Hao Long China 19 311 0.7× 280 0.7× 90 0.4× 67 0.6× 29 0.4× 53 843
Mark Whitmore United States 10 532 1.2× 678 1.7× 85 0.4× 93 0.9× 87 1.1× 15 1.2k
Atsushi Fukuoh Japan 17 371 0.8× 897 2.3× 70 0.3× 51 0.5× 127 1.6× 23 1.4k
Anbang Wang China 18 366 0.8× 724 1.8× 447 2.0× 95 0.9× 27 0.4× 41 1.3k
Rachel A. Harry United Kingdom 13 722 1.6× 614 1.6× 65 0.3× 176 1.7× 61 0.8× 14 1.6k
Jong-Young Kwak South Korea 14 761 1.7× 485 1.2× 84 0.4× 155 1.5× 43 0.6× 17 1.4k

Countries citing papers authored by Manyi Yang

Since Specialization
Citations

This map shows the geographic impact of Manyi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manyi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manyi Yang more than expected).

Fields of papers citing papers by Manyi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manyi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manyi Yang. The network helps show where Manyi Yang may publish in the future.

Co-authorship network of co-authors of Manyi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Manyi Yang. A scholar is included among the top collaborators of Manyi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manyi Yang. Manyi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jixiang, et al.. (2024). Overexpression of METTL14 mediates steatohepatitis and insulin resistance in mice. Heliyon. 10(15). e35467–e35467. 3 indexed citations
2.
Zhou, Jixiang, et al.. (2024). Gut microbiota regulates the ALK5/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167152–167152. 7 indexed citations
3.
Xie, Chunliang, Manyi Yang, Yingjun Zhou, et al.. (2022). Lactiplantibacillus plantarum AR113 Exhibit Accelerated Liver Regeneration by Regulating Gut Microbiota and Plasma Glycerophospholipid. Frontiers in Microbiology. 12. 800470–800470. 19 indexed citations
4.
Li, Bingxin, et al.. (2021). Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells. Frontiers in Oncology. 11. 663944–663944. 3 indexed citations
5.
Yang, Manyi & Maojun Zhou. (2020). Insertions and Deletions Play an Important Role in the Diversity of Conotoxins. The Protein Journal. 39(2). 190–195. 4 indexed citations
6.
Yang, Manyi & Maojun Zhou. (2020). μ-conotoxin TsIIIA, a peptide inhibitor of human voltage-gated sodium channel hNav1.8. Toxicon. 186. 29–34. 12 indexed citations
7.
Zhou, Maojun, Jinfeng Zhao, Qi Zhang, et al.. (2019). Nicotine Upregulates the Level of Mcl-1 through STAT3 in H1299 Cells. Journal of Cancer. 11(5). 1270–1276. 11 indexed citations
8.
Jin, Na, et al.. (2019). Detoxification and functionalization of gold nanorods with organic polymers and their applications in cancer photothermal therapy. Microscopy Research and Technique. 82(6). 670–679. 10 indexed citations
9.
Wang, Chengzhi, Xiaoqing Zhou, Hongjuan Xu, et al.. (2018). Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway. Journal of Cancer. 9(22). 4150–4155. 35 indexed citations
10.
Yang, Manyi, Shuang Zhao, Xiaoli Min, et al.. (2017). A novel μ-conotoxin from worm-hunting Conus tessulatus that selectively inhibit rat TTX-resistant sodium currents. Toxicon. 130. 11–18. 17 indexed citations
11.
Jiang, Qin, Manyi Yang, Zhan Qu, Jixiang Zhou, & Qi Zhang. (2017). Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells. BMC Complementary and Alternative Medicine. 17(1). 477–477. 48 indexed citations
12.
Zhou, Maojun, et al.. (2017). Phosphorylation of Bcl-2 plays an important role in glycochenodeoxycholate-induced survival and chemoresistance in HCC. Oncology Reports. 38(3). 1742–1750. 31 indexed citations
13.
Yang, Manyi, et al.. (2016). Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation. Oncology Reports. 36(4). 2193–2199. 33 indexed citations
14.
Huang, Huiqing, Shengfeng Huang, Yingcai Yu, et al.. (2011). Functional Characterization of a Ficolin-mediated Complement Pathway in Amphioxus. Journal of Biological Chemistry. 286(42). 36739–36748. 30 indexed citations
15.
Xu, Liqun, Shaochun Yuan, Jun Li, et al.. (2011). The conservation and uniqueness of the caspase family in the basal chordate, amphioxus. BMC Biology. 9(1). 60–60. 12 indexed citations
16.
Yang, Manyi, Shaochun Yuan, Shengfeng Huang, et al.. (2011). Characterization of bbtTICAM from amphioxus suggests the emergence of a MyD88-independent pathway in basal chordates. Cell Research. 21(10). 1410–1423. 27 indexed citations
17.
Yuan, Shaochun, Kui Wu, Manyi Yang, et al.. (2010). Amphioxus SARM Involved in Neural Development May Function as a Suppressor of TLR Signaling. The Journal of Immunology. 184(12). 6874–6881. 42 indexed citations
18.
Yuan, Shaochun, Tong Liu, Shengfeng Huang, et al.. (2009). Genomic and Functional Uniqueness of the TNF Receptor-Associated Factor Gene Family in Amphioxus, the Basal Chordate. The Journal of Immunology. 183(7). 4560–4568. 43 indexed citations
19.
Yuan, Shaochun, Shengfeng Huang, Wei Zhang, et al.. (2009). An amphioxus TLR with dynamic embryonic expression pattern responses to pathogens and activates NF-κB pathway via MyD88. Molecular Immunology. 46(11-12). 2348–2356. 59 indexed citations
20.
Huang, Shengfeng, Shaochun Yuan, Lei Guo, et al.. (2008). Genomic analysis of the immune gene repertoire of amphioxus reveals extraordinary innate complexity and diversity. Genome Research. 18(7). 1112–1126. 305 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinyao Mo Breakdown of academic impact, for papers by Zhigang Wang Breakdown of academic impact, for papers by Huaping Tang Breakdown of academic impact, for papers by Yu Zheng Breakdown of academic impact, for papers by Hao Long Breakdown of academic impact, for papers by Mark Whitmore Breakdown of academic impact, for papers by Atsushi Fukuoh Breakdown of academic impact, for papers by Anbang Wang Breakdown of academic impact, for papers by Rachel A. Harry Breakdown of academic impact, for papers by Jong-Young Kwak
Rankless by CCL
2026